alpheon
biopartners gmbh - recombinant human interferon alfa-2a - hepatitis c, chronisch - immunostimulants, - adult patients with histologically proven chronic hepatitis c who are positive for hepatitis c virus (hcv) antibodies or hcv rna and have elevated serum alanine aminotransferase (alt) without liver decompensation. the efficacy of interferon alfa-2a in the treatment of hepatitis c is enhanced when combined with ribavirin. alpheon should be given alone mainly in case of intolerance or contra-indication to ribavirin.
escitalopram ratiopharm gmbh 10 mg filmtabletten
ratiopharm arzneimittel vertriebs-gmbh - escitalopram oxalat - escitalopram
escitalopram ratiopharm gmbh 20 mg filmtabletten
ratiopharm arzneimittel vertriebs-gmbh - escitalopram oxalat - escitalopram
escitil 5 mg - filmtabletten
egis pharmaceuticals plc - escitalopram oxalat - escitalopram
escitil 10 mg - filmtabletten
egis pharmaceuticals plc - escitalopram oxalat - escitalopram
escitil 15 mg - filmtabletten
egis pharmaceuticals plc - escitalopram oxalat - escitalopram
escitil 20 mg - filmtabletten
egis pharmaceuticals plc - escitalopram oxalat - escitalopram
escitalobene 5 mg filmtabletten
ratiopharm arzneimittel vertriebs-gmbh - escitalopram oxalat - escitalopram
escitalobene 10 mg filmtabletten
ratiopharm arzneimittel vertriebs-gmbh - escitalopram oxalat - escitalopram
escitalobene 15 mg filmtabletten
ratiopharm arzneimittel vertriebs-gmbh - escitalopram oxalat - escitalopram